🧪 Hypotheses

therapeutic 1.00

Metabolic Reprogramming to Reverse Senescence

🧬 SIRT1,PGC1A,NAMPT 🏥 N/A

✅ 0.90 ✨ 0.60 💥 0.82

# Metabolic Reprogramming to Reverse Senescence in Neurodegeneration: A Mechanistic Hypothesis...

therapeutic 0.89

H1: TREM2 Agonism to Redirect APOE4-Enhanced Microglia from Synapse Pruning to Amyloid Clearance

🧬 TREM2 🏥 neurodegeneration

✅ 0.82 ✨ 0.65 💥 0.75

## Mechanistic Overview...

therapeutic 0.81

AMPK hypersensitivity in astrocytes creates enhanced mitochondrial rescue responses

🧬 PRKAA1 🏥 neurodegeneration

✅ 0.85 ✨ 0.80 💥 0.75

## Mechanistic Overview...

therapeutic 0.81

Neutrophil Extracellular Trap (NET) Inhibition

🧬 PADI4 🏥 N/A

✅ 0.00 ✨ 0.00 💥 0.00

## Mechanistic Overview...

therapeutic 0.80

Dual-Receptor Antibody Shuttling

🧬 N/A 🏥 Alzheimer's disease

✅ 0.00 ✨ 0.00 💥 0.00

## Mechanistic Overview...

therapeutic 0.80

Microglial TREM2-SYK Pathway Enhancement

🧬 TREM2 🏥 neurodegeneration

✅ 0.70 ✨ 0.60 💥 0.80

## Mechanistic Overview...

therapeutic 0.79

VCP-Mediated Autophagy Enhancement

🧬 VCP 🏥 neurodegeneration

✅ 0.00 ✨ 0.00 💥 0.00

## Mechanistic Overview...

therapeutic 0.78

Selective HDAC3 Inhibition with Cognitive Enhancement

🧬 HDAC3 🏥 neurodegeneration

✅ 0.70 ✨ 0.85 💥 0.80

## Mechanistic Overview...

therapeutic 0.77

Chromatin Accessibility Restoration via BRD4 Modulation

🧬 BRD4 🏥 neurodegeneration

✅ 0.60 ✨ 0.90 💥 0.70

## Mechanistic Overview...

therapeutic 0.74

Circadian-Synchronized Proteostasis Enhancement

🧬 CLOCK/ULK1 🏥 neurodegeneration

✅ 0.60 ✨ 0.80 💥 0.70

# Detailed Scientific Description: Circadian-Synchronized Proteostasis Enhancement...

therapeutic 0.74

PARP1 Inhibition Therapy

🧬 PARP1 🏥 neurodegeneration

✅ 1.00 ✨ 0.70 💥 0.60

## Mechanistic Overview...

therapeutic 0.73

SMPD1 (Acid Sphingomyelinase) Inhibition for Ceramide Reduction and BACE1 Regulation

🧬 SMPD1 🏥 neurodegeneration

✅ 0.82 ✨ 0.55 💥 0.75

**Molecular Mechanism and Rationale**...

therapeutic 0.72

Proteostasis Enhancement via APOE Chaperone Targeting

🧬 HSPA1A 🏥 neurodegeneration

✅ 0.85 ✨ 0.70 💥 0.75

## Mechanistic Overview...

therapeutic 0.71

Matrix Stiffness Normalization via Targeted Lysyl Oxidase Inhibition

🧬 LOX/LOXL1-4 🏥 neurodegeneration

✅ 0.75 ✨ 0.80 💥 0.70

## **Molecular Mechanism and Rationale**...

therapeutic 0.70

Targeted Butyrate Supplementation for Microglial Phenotype Modulation

🧬 GPR109A 🏥 neurodegeneration

✅ 0.90 ✨ 0.60 💥 0.80

## Mechanistic Overview...

therapeutic 0.69

Astrocytic Lipoxin A4 Pathway Restoration via ALOX15 Gene Therapy

🧬 ALOX15 🏥 neurodegeneration

✅ 0.40 ✨ 0.70 💥 0.70

## Mechanistic Overview...

therapeutic 0.68

STMN2 Restoration as a Prerequisite for Axon Growth After TDP-43 Clearance

🧬 STMN2 🏥 neurodegeneration

✅ 0.85 ✨ 0.70 💥 0.82

**Molecular Mechanism and Rationale**...

therapeutic 0.68

Temporal CAG Repeat Stabilization via CRISPR-Mediated DNA Mismatch Repair Modulation

🧬 MSH3, PMS1 🏥 neurodegeneration

✅ 0.40 ✨ 0.75 💥 0.70

## Mechanistic Overview...

therapeutic 0.68

R-Loop Resolution Enhancement Therapy

🧬 SETX 🏥 neurodegeneration

✅ 0.45 ✨ 0.80 💥 0.60

## Mechanistic Overview...

therapeutic 0.67

TREM2 R47H Metabolic Lock-in at Cholesterol Ester Accumulation

🧬 TREM2/ACAT1/LXR 🏥 neuroimmunology

✅ 0.55 ✨ 0.65 💥 0.72

## Mechanistic Overview...

therapeutic 0.66

RNA Granule Nucleation Site Modulation

🧬 G3BP1 🏥 neurodegeneration

✅ 0.60 ✨ 0.65 💥 0.70

## Mechanistic Overview...

therapeutic 0.65

Arginine Methylation Enhancement Therapy

🧬 PRMT1 🏥 neurodegeneration

✅ 0.50 ✨ 0.90 💥 0.80

## Molecular Mechanism and Rationale...

therapeutic 0.65

Mitochondrial Calcium Buffering Enhancement via MCU Modulation

🧬 MCU 🏥 neurodegeneration

✅ 0.50 ✨ 0.60 💥 0.30

## Mechanistic Overview...

therapeutic 0.65

Apoptosis-Senescence Decision Point Intervention

🧬 TP53,BAX,BAK1,CASP3 🏥 N/A

✅ 0.20 ✨ 0.80 💥 0.00

## Mechanistic Overview...

therapeutic 0.65

CLU-APOE-TREM2 Tripartite Axis as a Coordinate Therapeutic Target

🧬 CLU-APOE-TREM2 axis (LXR/RXR pathway) 🏥 neurodegeneration

✅ 0.45 ✨ 0.55 💥 0.78

## Mechanistic Overview...

therapeutic 0.65

Epigenetic Reprogramming of Microglial Memory

🧬 DNMT3A, HDAC1/2 🏥 Alzheimer's disease

✅ 0.80 ✨ 0.80 💥 0.70

## Mechanistic Overview...

therapeutic 0.64

Glycine-Rich Domain Competitive Inhibition

🧬 TARDBP 🏥 neurodegeneration

✅ 0.45 ✨ 0.70 💥 0.60

## Mechanistic Overview...

therapeutic 0.63

Peripheral-to-Central Inflammation Circuit Breaker

🧬 IL1B 🏥 N/A

✅ 0.00 ✨ 0.00 💥 0.00

## Mechanistic Overview...

therapeutic 0.62

Serine/Arginine-Rich Protein Kinase Modulation

🧬 SRPK1 🏥 neurodegeneration

✅ 0.60 ✨ 0.70 💥 0.50

## Mechanistic Overview...

therapeutic 0.62

TREM2 Agonism to Reprogram Infiltrated Monocytes Toward Neuroprotective Phenotype

🧬 TREM2 🏥 neurodegeneration

✅ 0.45 ✨ 0.75 💥 0.55

## Mechanistic Overview...